Listen: The latest on the China virus, Sarepta’s ongoing FDA saga, and biotech at Davos

Are we dealing with a SARS redux? Has the FDA lost its teeth? And what do billionaires talk to each other about?

We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, STAT’s Helen Branswell joins us to break down what’s known, unknown, and yet to come for the viral outbreak in China. Then, we talk about this week’s World Economic Forum, which has turned out not to be a venue for substantive discussions about drug development. Finally, our colleague Matthew Herper dials in to discuss the latest twist in the Sarepta Therapeutics saga and why it has some people alarmed about the future of the FDA.

Read the rest…

Read Original Article: Listen: The latest on the China virus, Sarepta’s ongoing FDA saga, and biotech at Davos »